ALGS Stock Analysis: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$7.52
-0.43 (-5.41%)
▼
5d:
-12.46%
30d:
-17.63%
90d:
-8.85%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 09, 2026
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALGS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ALGS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $7.52, which is considered oversold relative to its 30-day fair value range of $7.98 to $9.40.
Technical Outlook: Technically, ALGS is showing sideways momentum. Immediate support is located at $7.23, while resistance sits at $8.99. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: ALGS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $68.20 (+806.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALGS is showing sideways momentum. Immediate support is located at $7.23, while resistance sits at $8.99. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: ALGS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $68.20 (+806.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$7.98 -
$9.40
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 806.9% below Wall St target ($68.20)
- CAUTION: 5-day price weakness (-12.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$7.98 -
$9.40
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$7.23
Resistance Level
$8.99
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-1.06
Wall Street Target
$68.20
(+806.9%)
Revenue Growth (YoY)
-41.6%
Last updated: February 03, 2026 4:48 PM ET
Data refreshes hourly during market hours. Next update: 5:48 PM
Data refreshes hourly during market hours. Next update: 5:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
